06.21.16
Pharmatek has expanded its spray drying capabilities with the purchase of a second GEA Niro Mobile Minor, in addition to a ProCepT 4M8-Trix, and a GEA Niro SD Micro for the development and GMP manufacture of amorphous spray dried dispersions (SDD). The company’s existing spray drying equipment included a GEA Niro Mobile Minor and a Buchi B-290.
"Expanding our SDD capacity is driven by significant client demand and is part of Pharmatek's continuing efforts to provide a comprehensive range of bioavailability enhancement solutions for our clients," said Tim Scott, president of Pharmatek. "We are committed to adding new technologies and increasing capacity in development areas that our clients care about."
Pharmatek offers formulation development, process scale-up and GMP manufacturing services for small molecules and peptides. Spray drying is part of the company's amorphous dispersion drug development capabilities that include physical characterization , preformulation testing, analytical development, formulation development and GMP manufacturing of finished dosage forms.
Visit Pharmatek at Table 23
"Expanding our SDD capacity is driven by significant client demand and is part of Pharmatek's continuing efforts to provide a comprehensive range of bioavailability enhancement solutions for our clients," said Tim Scott, president of Pharmatek. "We are committed to adding new technologies and increasing capacity in development areas that our clients care about."
Pharmatek offers formulation development, process scale-up and GMP manufacturing services for small molecules and peptides. Spray drying is part of the company's amorphous dispersion drug development capabilities that include physical characterization , preformulation testing, analytical development, formulation development and GMP manufacturing of finished dosage forms.
Visit Pharmatek at Table 23
